TAIPEI, Taiwan, Sept. 02, 2025 (GLOBE NEWSWIRE) -- OBI Pharma, a clinical-stage oncology company (4174.TWO), today announced the initiation of a Phase 1/2 clinical trial of OBI-902, an antibody-drug ...

The global bioconjugation market is set to witness a growth rate of ~13% in the next 5 years. Increasing demand for targeted ...

Singapore Summit, which co-hosted by WuXi XDC (Stock Code: 2268.HK), was successfully concluded from4-26, 2025. The conference brought together leading biopharmaceutical companies and research ...

Traditional microbial expression systems can be advanced through improved plasmid replication, target gene transcription, translation, and safety. This provides a robust foundation for stable and ...

Preclinical data presented at the 10th Annual CAR-TCR Summit demonstrated deep depletion of B cells in blood and tissue in humanized mouse models and non-human primates, supporting nomination of ...

What was once a problem of square footage is now a question of readiness. Only those who invest ahead of demand while staying lean and interoperable will be able to support the next wave of complex ...

Mycenax Biotech and Spera Pharma collaborate to streamline ADC drug substance and drug product manufacturing services: Taiwan Tuesday, September 16, 2025, 16:00 Hrs [IST] Mycenax ...

OSE Immunotherapeutics, Inserm Transfert and Nantes University Announce Strategic Partnership to Accelerate Innovation in Immunotherapy ...

Synaffix has entered a licensing agreement with South Korean biopharmaceutical firm Qurient to develop a dual-payload ADC.

The National Testing Agency is expected to begin the application process for CSIR UGC NET December 2025 in due course. Candidates interested in applying for the exam will be able to submit their ...

That moment when you open Netflix and it somehow knows exactly what you want to watch? That’s AI doing what it does best.Your ...